Company Filing History:
Years Active: 1997
Title: Pierre M Bay: Innovator in Retroviral Particle Production
Introduction
Pierre M Bay is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of virology, particularly in the production and purification of retroviral particles. His innovative approach has the potential to enhance the efficiency of viral particle production, which is crucial for various medical applications.
Latest Patents
Pierre M Bay holds 1 patent related to his work. His patent, titled "Production and purification of retroviral particles using tentacle anion," describes a continuous process for producing viral particles. This process involves providing a population of viable virally infected non-lytic cells in a perfused growth medium. The method includes removing the medium containing these cells at a rate that maintains the steady-state log-phase growth of the remaining cells. Additionally, the invention outlines a purification process for retroviral particles by passing a solution through an anion exchange resin, specifically a tentacle anion exchange resin, to elute the retroviral particles from the resin.
Career Highlights
Pierre M Bay is associated with The Immune Response Corporation, where he applies his expertise in virology and particle production. His work is instrumental in advancing the understanding and application of retroviral technologies.
Collaborations
Pierre has collaborated with notable colleagues, including Michael E Hrinda and Christopher P Prior. These collaborations have likely contributed to the development and refinement of his innovative processes.
Conclusion
Pierre M Bay's contributions to the field of retroviral particle production exemplify the impact of innovation in medical research. His patent and work at The Immune Response Corporation highlight the importance of continuous advancements in virology.